Oticon Medical Hosts Good Vibrations Day 2025
Good Vibrations Day is an inclusive, non-branded campaign aimed at educating the public about bone conduction as a hearing treatment.
Good Vibrations Day is an inclusive, non-branded campaign aimed at educating the public about bone conduction as a hearing treatment.
Bone Anchored Awareness Day was established in 2021 as a non-branded day to raise awareness, celebrate bone anchored hearing as a treatment, and give voice to users around the globe.
Oticon Medical announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from appropriately fitted hearing aid(s).
Ear Community is a 501c3 nonprofit organization that helps Microtia and Atresia families around the world.
Read MoreAs President, Sparacio will have responsibility for leadership of the entire US organization and the advancement of Oticon Medical’s position in bone-anchored hearing systems and cochlear implant solutions in the US.
Read MoreThe Safety Line consists of a clip connected to an elastic line with a loop that attaches to both the Ponto Sound Processor and clothing. The user-friendly clip features a firm “barbed” grip and no sharp edges.
Read MoreWith two, ready-mounted connector plates for the Ponto Sound Processor, the bilateral Ponto Softband is designed to ensure a stable fit and best audiological outcome for users.
Read MoreMore than 100 hearing care professionals from across the US participated in a collaborative pediatric conference co-sponsored by Oticon Pediatrics, Oticon Medical, Interacoustics, and Hearing Screening Associates, held November 3-5 in Glenview, Ill.
Read MoreOticon Medical has obtained 510(k) clearance from the FDA to market the powerful new Ponto 3 bone-anchored, abutment-level sound processor, which has a fitting range down to 65 dB HL (BC).
Read MoreOticon Medical announced that it obtained 510(k) clearance from the FDA to market the Ponto Abutment Extension for bone anchored hearing. The new abutment extension connects to existing abutments so users can upgrade their bone anchored hearing solutions without changing abutments or undergoing further surgery.
Read MoreThe FDA has cleared two new Oticon Medical products for marketing in the US: The Minimally Invasive Ponto Surgery (MIPS), an update of the tissue preservation surgery for use with the company’s Ponto System; and the Ponto BHX Implant, which has a laser-ablated titanium surface that promotes a faster and stronger bonding to bone, and is designed to increase the strength of the bone-to-implant interface by more than 150%.
Read MoreOticon Medical announced that its 4th annual Scientific Meeting drew more than 90 professionals representing 23 countries to its headquarters in Copenhagen. The 3-day conference combined scientific presentations, lectures, and roundtable discussions with focused programs concentrating on audiology and surgery.
Read MoreOticon Medical mourns the passing of Curt Gorman, who was the senior vice president of its BAHS Division. Gorman had been a valued member of the management team since Oticon Medical’s inception in 2009.
Read MoreThe Oticon Medical Great Debate in BAHS 2015 event stimulated knowledge sharing, opinions and insights on best treatments and approaches in bone-anchored hearing care.
Read MoreOticon Medical announced the appointment of Jared Schnackenberg as president of Oticon Medical US. He will provide overall leadership for the entire US organization to further develop Oticon Medical’s position in the bone anchored hearing solutions (BAHS) market and to prepare for the anticipated launch of Oticon Medical Cochlear Implants for the US market.
Read MoreOticon Medical has launched its Medical Streamer and ConnectLine App, enabling Ponto Plus sound processor users to control their bone anchored hearing solutions with just a tap of their iPhone, iPad, and iPod touch.
Read More